臨床藥學學科

Medicine & Life Sciences

1. Taiwan 100%
2. Mucocutaneous Lymph Node Syndrome 51%
3. Population 50%
4. Cohort Studies 40%
5. Pharmacists 26%
6. aristolochic acid I 25%
7. High Pressure Liquid Chromatography 24%
8. Lactic Acid 24%
9. Single Nucleotide Polymorphism 23%
10. Stromal Interaction Molecule 1 22%
11. Genes 21%
12. Pyruvaldehyde 21%
13. Kidney 19%
14. Neoplasms 19%
15. Intravenous Immunoglobulins 19%
16. Olanzapine 19%
17. Metformin 18%
18. Breast Neoplasms 18%
19. Therapeutics 18%
20. Pharmaceutical Preparations 18%
21. Databases 17%
22. 3-Hydroxybutyric Acid 17%
23. National Health Programs 17%
24. Costs and Cost Analysis 17%
25. Ankylosing Spondylitis 16%
26. Calcium 16%
27. alkannin 15%
28. Cost-Benefit Analysis 15%
29. Genetic Polymorphisms 14%
30. Cyclooxygenase 2 14%
31. Confidence Intervals 14%
32. Osteoporosis 14%
33. Diabetes Mellitus 13%
34. Stroke 13%
35. Retrospective Studies 13%
36. Health Care Costs 13%
37. desmethylolanzapine 13%
38. isosteviol 12%
39. shikonin 12%
40. Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
41. Colorectal Neoplasms 12%
42. Crystallins 12%
43. Gene Expression 11%
44. Pharmacokinetics 11%
45. Coronary Vessels 11%
46. Tandem Mass Spectrometry 11%
47. Colonic Neoplasms 11%
48. 4-nitro-7-piperazino-2,1,3-benzoxadiazole 11%
49. Serum 11%
50. Interleukin-8 11%
51. Calcium Channels 11%
52. Macrophages 10%
53. Liquid Chromatography 10%
54. Proteins 10%
55. D-Aspartic Acid 10%
56. Prescriptions 10%
57. Nephrolithiasis 10%
58. Schizophrenia 10%
59. Streptozocin 10%
60. Singapore 9%
61. Lung Neoplasms 9%
62. Rabbits 9%
63. Fluorescence 9%
64. MicroRNAs 9%
65. In Vitro Techniques 9%
66. astaxanthine 9%
67. Gout 9%
68. Selenious Acid 9%
69. Urine 9%
70. Lipopolysaccharides 8%
71. Type 2 Diabetes Mellitus 8%
72. Chitosan 8%
73. Cell Movement 8%
74. Inflammation 8%
75. E coli Lon protein 8%
76. Apoptosis 8%
77. Rheumatoid Arthritis 8%
78. Zolpidem 8%
79. Gentamicins 8%
80. Pharmacy 8%
81. Tuberculosis 8%
82. Urinary Bladder 8%
83. Gastrointestinal Diseases 8%
84. Neoplasm Metastasis 8%
85. Child 7%
86. Acids 7%
87. Chronic Kidney Failure 7%
88. Odds Ratio 7%
89. Health Surveys 7%
90. Liver 7%
91. Cytokines 7%
92. Methanol 7%
93. Anti-Inflammatory Agents 7%
94. Computational Biology 7%
95. Health Expenditures 7%
96. Warfarin 7%
97. Medication Reconciliation 7%
98. Genotype 7%
99. Transcription Factor AP-1 7%

Chemical Compounds

1. Genetic Polymorphism 25%
2. Aristolochic Acid 23%
3. Methylglyoxal 17%
4. Protein 16%
5. 3-Hydroxybutyrate 14%
6. High-Pressure Liquid Chromatography 14%
7. Alkannin 13%
8. Shikonin 12%
9. Enantiomer 12%
10. Plasma 11%
11. Composite Material 11%
12. Calcium(0) 11%
13. Creatinine 10%
14. Dose 9%
15. Astaxanthin 9%
16. Column Like Crystal 9%
17. Application 8%
18. Disorder 8%
19. Drug 7%
20. Liquid Film 7%
21. Fluorescence 7%
22. Graphene 7%
23. Resistance 6%
24. Reactive Oxygen Metabolite 6%
25. Laser Capture Microdissection 6%
26. Marker 6%
27. Metformin 6%
28. Dexamethasone 6%
29. Glucose 6%
30. Nephrotoxic 6%
31. Lactate 6%
32. Acid 6%
33. Metabolite 6%
34. Olanzapine 6%
35. Multi Walled Nanotube 5%
36. Nanoparticle 5%
37. Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 5%
38. Antiinflammatory 5%
39. Selenites 5%
40. Polyimide Macromolecule 5%
41. Pharmacokinetics 5%